How many FDA warning letters has ORIENT PHARMA received?

Argus HQ has not recorded an FDA warning letter for ORIENT PHARMA in our current dataset.

What FDA recalls has ORIENT PHARMA issued?

Argus HQ has not recorded an FDA recall tied to ORIENT PHARMA in our current dataset.

Is ORIENT PHARMA FDA compliant?

Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 1 approval record for ORIENT PHARMA. Review the linked FDA source records directly before drawing a compliance conclusion.

.hq

company

ORIENT PHARMA

Name: FDA Enforcement Actions Against ORIENT PHARMA
Creator: Argus HQ
License: https://argushq.ai/methodology

Jurisdiction: US

FDA Warning Letter timeline

V1 scope: FDA Warning Letters only. Additional public-record sources (SEC, CPSC, federal contracts) are on the V2 roadmap and are not surfaced here today.

fda_approval · anda2026-06-09
ORIENT PHARMA — ANDA approval: TOFACITINIB CITRATE (unspecified)

Frequently asked questions

How many FDA warning letters has ORIENT PHARMA received?: Argus HQ has not recorded an FDA warning letter for ORIENT PHARMA in our current dataset.
What FDA recalls has ORIENT PHARMA issued?: Argus HQ has not recorded an FDA recall tied to ORIENT PHARMA in our current dataset.
Is ORIENT PHARMA FDA compliant?: Argus HQ is not a compliance rating service. As of this page's last update, our dataset shows 0 warning letters, 0 recalls, and 1 approval record for ORIENT PHARMA. Review the linked FDA source records directly before drawing a compliance conclusion.

Informational only. FDA Warning Letters are public records (17 USC §105). Summaries are AI-assisted and may contain errors; always verify against the original FDA letter before acting. Not legal, financial, or regulatory advice.